Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Gene-Knocked Out Chimeric Antigen Receptor (Car) T Cells: Tuning up for the Next Generation Cancer Immunotherapy Publisher Pubmed



Mirzaei HR1 ; Pourghadamyari H2 ; Rahmati M3 ; Mohammadi A4 ; Nahand JS5 ; Rezaei A6 ; Mirzaei H7 ; Hadjati J1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Clinical Biochemistry, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  3. 3. Department of Medical Biotechnology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran
  4. 4. Department of Biochemistry and Physiology Research Center, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  5. 5. Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  7. 7. Department of Biomaterials, Tissue Engineering and Nanotechnology, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Cancer Letters Published:2018


Abstract

Recently clinical trials utilizing genetically engineered T cells expressing a chimeric antigen receptor (CAR) that is half monoclonal antibody and half T-cell receptor have demonstrated remarkable response in patients with advanced cancers like relapsed or refractory acute lymphoblastic leukemia (ALL) and lymphoma. Moreover, emerging chimeric genome editing tools such as zinc-finger nucleases (ZNFs), transcription activator-like effector nucleases (TALENs) and clustered regulatory interspaced short palindromic repeat (CRISPR)/Cas composed of sequence-specific DNA binding module(s) linked to a non-specific DNA cleavage domain have made possible to dramatically expand the ability to manipulate cells aim to treat and/or study a wide range of diseases including cancer. Here, we will discuss how joint application of these two chimeras will help us to manipulate CAR T cells aiming to enhance the efficacy of CAR T cell therapy in preclinical and clinical settings. © 2018 Elsevier B.V.
Related Docs
View other Related Docs
1. Cervical Cancer Diagnosis: Insights Into Biochemical Biomarkers and Imaging Techniques, Combinatorial Chemistry and High Throughput Screening (2021)
2. Gastric Cancer Diagnosis: From Imaging Techniques to Biochemical Biomarkers, Current Molecular Medicine (2021)
3. Mesenchymal Stem Cells: A New Platform for Targeting Suicide Genes in Cancer, Journal of Cellular Physiology (2018)
4. Diet and Cancer Prevention: Dietary Compounds, Dietary Micrornas, and Dietary Exosomes, Journal of Cellular Biochemistry (2018)
5. Crispr–Cas9 in Genome Editing: Its Function and Medical Applications, Journal of Cellular Physiology (2019)
6. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
7. Microrna: A Novel Target of Curcumin in Cancer Therapy, Journal of Cellular Physiology (2018)
8. The Story of Nanoparticles in Differentiation of Stem Cells Into Neural Cells, Neurochemical Research (2019)
Experts (# of related papers)
View all Related Experts
Bahman Rashidi (5)
Rasoul Salehi (4)
Other Related Docs
9. Nivolumab Plus Ipilimumab Combination Therapy in Cancer: Current Evidence to Date, International Immunopharmacology (2023)
10. Imaging Techniques: New Avenues in Cancer Gene and Cell Therapy, Cancer Gene Therapy (2017)
11. Molecular Aspects of Diabetes Mellitus: Resistin, Microrna, and Exosome, Journal of Cellular Biochemistry (2018)
12. Stem Cell- and Gene-Based Therapies As Potential Candidates in Alzheimer's Therapy, Journal of Cellular Biochemistry (2018)
13. Direct Conjugation of Retinoic Acid With Gold Nanoparticles to Improve Neural Differentiation of Human Adipose Stem Cells, Journal of Molecular Neuroscience (2020)
14. The Role of Immune Regulatory Molecules in Multiple Sclerosis, Journal of Neuroimmunology (2019)
15. Fabrication and Evaluation of a Dual-Targeting Nanoparticle Mediated Crispr/Cas9 Delivery to Combat Drug Resistance in Breast Cancer Cells, Journal of Drug Delivery Science and Technology (2023)
16. The Role of Bone Marrow Microenvironment (Bmm) Cells in Acute Myeloid Leukemia (Aml) Progression: Immune Checkpoints, Metabolic Checkpoints, and Signaling Pathways, Cell Communication and Signaling (2023)
17. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
18. Targeting Immune Checkpoints: How to Use Natural Killer Cells for Fighting Against Solid Tumors, Cancer Communications (2023)
19. Inducing Chimeric Antigen Receptor (Car) Regulatory T Cells In-Vivo: A Novel Concept for a Potential Feasible Cure of Demyelinating Diseases, Multiple Sclerosis and Related Disorders (2022)
20. Computational Study for Suppression of Cd25/Il-2 Interaction, Biological Chemistry (2021)
21. Genetically Engineered Mesenchymal Stem Cells: Targeted Delivery of Immunomodulatory Agents for Tumor Eradication, Cancer Gene Therapy (2020)
22. The Therapeutic Potential of Human Adipose-Derived Mesenchymal Stem Cells Producing Cxcl10 in a Mouse Melanoma Lung Metastasis Model, Cancer Letters (2018)
23. Genetic Advancements in Breast Cancer Treatment: A Review, Discover Oncology (2025)
24. Nanomicellar-Curcumin Exerts Its Therapeutic Effects Via Affecting Angiogenesis, Apoptosis, and T Cells in a Mouse Model of Melanoma Lung Metastasis, Pathology Research and Practice (2020)
25. Ovarian Stimulation and Exogenous Progesterone Affect the Endometrial Mir-16-5P, Vegf Protein Expression, and Angiogenesis, Microvascular Research (2021)
26. Breast Cancer Diagnosis: Imaging Techniques and Biochemical Markers, Journal of Cellular Physiology (2018)
27. Mirna-Based Strategy for Modulation of Influenza a Virus Infection, Epigenomics (2018)
28. Exosomes and Micrornas: New Potential Therapeutic Candidates in Alzheimer Disease Therapy, Journal of Cellular Physiology (2019)
29. Chimeric Antigen Receptor-T Cells Immunotherapy for Targeting Breast Cancer, Research in Pharmaceutical Sciences (2021)
30. The Kinetics of Inhibitory Immune Checkpoints During and Post-Covid-19: The Knowns and Unknowns, Clinical and Experimental Medicine (2023)
31. Exploring Advanced Crispr Delivery Technologies for Therapeutic Genome Editing, Small Science (2024)
32. Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition in Cancer: Nanotechnology Comes Into View, Journal of Cellular Physiology (2018)
33. A Novel Car Expressing Nk Cell Targeting Cd25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers, Frontiers in Oncology (2021)
34. Cxcl-10: A New Candidate for Melanoma Therapy?, Cellular Oncology (2020)
35. Chemopreventive and Therapeutic Potential of Curcumin in Esophageal Cancer: Current and Future Status, International Journal of Cancer (2019)
36. Harnessing Crispr/Cas9 Technology in Cardiovascular Disease, Trends in Cardiovascular Medicine (2020)
37. Micro-Rnas As Critical Regulators of Matrix Metalloproteinases in Cancer, Journal of Cellular Biochemistry (2018)
38. Tim3 and Pd-1 As a Therapeutic and Prognostic Targets in Colorectal Cancer: Relationship With Sidedness, Clinicopathological Parameters, and Survival, Frontiers in Oncology (2023)
39. Chondrogenic Differentiation of Human Scalp Adipose-Derived Stem Cells in Polycaprolactone Scaffold and Using Freeze Thaw Freeze Method, Journal of Cellular Physiology (2018)
40. Molecular Aspects of Pancreatic Β-Cell Dysfunction: Oxidative Stress, Microrna, and Long Noncoding Rna, Journal of Cellular Physiology (2019)
41. Crispr Technology: A Versatile Tool to Model, Screen, and Reverse Drug Resistance in Cancer, European Journal of Cell Biology (2023)
42. Endometrial Pinopode Biomarkers: Molecules and Micrornas, Journal of Cellular Physiology (2018)